Risk of Fracture with Thiazolidinediones: Disease or Drugs?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Risk of Fracture with Thiazolidinediones: Disease or Drugs?

Published:2012-04-10 Issue:6 Volume:90 Page:450-457
ISSN:0171-967X
Container-title:Calcified Tissue International
language:en
Short-container-title:Calcif Tissue Int

Author:

Bazelier Marloes T.,Vestergaard Peter,Gallagher Arlene M.,van Staa Tjeerd-Pieter,Cooper Cyrus,Leufkens Hubert G. M.,de Vries Frank

Publisher

Springer Science and Business Media LLC

Subject

Endocrinology,Orthopedics and Sports Medicine,Endocrinology, Diabetes and Metabolism

Link

http://link.springer.com/content/pdf/10.1007/s00223-012-9591-8

Reference34 articles.

1. Yki-Jarvinen H (2004) Thiazolidinediones. N Engl J Med 351:1106–1118

2. Schernthaner G, Chilton RJ (2010) Cardiovascular risk and thiazolidinediones—what do meta-analyses really tell us? Diabetes Obes Metab 12(12):1023–1035

3. Erdmann E, Dormandy JA, Charbonnel B, Massi-Benedetti M, Moules IK, Skene AM, PROactive Investigators (2007) The effect of pioglitazone on recurrent myocardial infarction in 2,445 patients with type 2 diabetes and previous myocardial infarction: results from the PROactive (PROactive 05) study. J Am Coll Cardiol 49(17):1772–1780

4. Grey A (2008) Skeletal consequences of thiazolidinedione therapy. Osteoporos Int 19(2):129–137

5. Benvenuti S, Cellai I, Luciani P, Deledda C, Baglioni S, Giuliani C, Saccardi R, Mazzanti B, Dal Pozzo S, Mannucci E, Peri A, Serio M (2007) Rosiglitazone stimulates adipogenesis and decreases osteoblastogenesis in human mesenchymal stem cells. J Endocrinol Invest 30(9):RC26–RC30

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thiazolidinedione as a Promising Medicinal Scaffold for the Treatment of Type 2 Diabetes;Current Diabetes Reviews;2023-10-20

2. Agonist-controlled competition of RAR and VDR nuclear receptors for heterodimerization with RXR is manifested in their DNA binding;Journal of Biological Chemistry;2023-02

3. Glucose-Lowering Drugs and Fracture Risk—a Systematic Review;Current Osteoporosis Reports;2020-11-09

4. Drug-Induced Male Osteoporosis;Trends in Andrology and Sexual Medicine;2020

5. DPP-4 inhibitor impedes lipopolysaccharide-induced osteoclast formation and bone resorption in vivo;Biomedicine & Pharmacotherapy;2019-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3